Moderna’s norovirus vaccine trial placed on FDA hold over reported case of Guillain-Barré syndrome
A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological ...
Moderna's norovirus vaccine trial paused due to a rare neurological effect, Citadel's short position in GSK, bird flu response issues during Trump's term, WHO's call for alcohol warning labels, and ...
LANSING, Mich. (WILX) - Roughly one-tenth of the workforce at the Centers for Disease Control and Prevention are expected to ...
The neurologist explains the link between Guillain-Barre Syndrome and paralysis, and the initial symptoms to watch out for.
Health News LIVE UPDATES: Stay informed with the latest developments in healthcare as we bring you real-time updates on crucial health initiatives, groundbreaking research, and government health ...
Health News Live Updates: We you the latest in health and wellness, offering timely news, expert insights, and essential trends to keep you informed and empowered to make healthier decisions. Stay ...
Earnings: Discover insights into revenue shifts, cost reductions, 2027 product goals, RSV market strategies, and its broader ...
In its fourth-quarter earnings report, Moderna’s revenue was down substantially from 2023. Separately, media reports reveal anticipated cuts to the company’s digital team.
Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 ...
The cases of Guillain-Barré Syndrome (GBS) are rising in Maharashtra day by day, three new suspected cases of GBS were reported on Saturday, with the toll reaching 183 and deaths at six.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results